IL150698A0 - Processes for preparing clarithromycin polymorphs - Google Patents

Processes for preparing clarithromycin polymorphs

Info

Publication number
IL150698A0
IL150698A0 IL15069800A IL15069800A IL150698A0 IL 150698 A0 IL150698 A0 IL 150698A0 IL 15069800 A IL15069800 A IL 15069800A IL 15069800 A IL15069800 A IL 15069800A IL 150698 A0 IL150698 A0 IL 150698A0
Authority
IL
Israel
Prior art keywords
processes
clarithromycin
preparing clarithromycin
polymorphs
converting
Prior art date
Application number
IL15069800A
Other languages
English (en)
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22640371&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL150698(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of IL150698A0 publication Critical patent/IL150698A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL15069800A 2000-01-11 2000-12-15 Processes for preparing clarithromycin polymorphs IL150698A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17547700P 2000-01-11 2000-01-11
PCT/US2000/033844 WO2001051059A1 (en) 2000-01-11 2000-12-15 Processes for preparing clarithromycin polymorphs

Publications (1)

Publication Number Publication Date
IL150698A0 true IL150698A0 (en) 2003-02-12

Family

ID=22640371

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15069800A IL150698A0 (en) 2000-01-11 2000-12-15 Processes for preparing clarithromycin polymorphs

Country Status (22)

Country Link
US (2) US6624292B2 (pt)
EP (1) EP1280535B1 (pt)
JP (1) JP2003519661A (pt)
KR (1) KR20020071012A (pt)
CN (1) CN1450903A (pt)
AT (1) ATE288758T1 (pt)
AU (2) AU2001222619C1 (pt)
BR (1) BR0016992A (pt)
CA (1) CA2397092A1 (pt)
DE (1) DE60018119T2 (pt)
DK (1) DK1280535T3 (pt)
ES (1) ES2236023T3 (pt)
HR (1) HRP20020572A2 (pt)
HU (1) HUP0204252A3 (pt)
IL (1) IL150698A0 (pt)
IS (1) IS6463A (pt)
PL (1) PL356645A1 (pt)
PT (1) PT1280535E (pt)
RU (1) RU2002118308A (pt)
SI (1) SI1280535T1 (pt)
WO (1) WO2001051059A1 (pt)
ZA (1) ZA200205229B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL150227A0 (en) * 1999-12-16 2002-12-01 Teva Pharma Processes for preparing clarithromycin polymorphs and novel polymorph iv
ATE288758T1 (de) * 2000-01-11 2005-02-15 Teva Pharma Verfahren zur herstellung von polymorphen des clarithromycins
US6544555B2 (en) * 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
IL151496A0 (en) * 2000-02-29 2003-04-10 Teva Pharma Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
AU2001263812B2 (en) * 2000-03-28 2004-09-23 Sandoz Ag Granulated particles with masked taste
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
EP1285659B1 (en) * 2001-08-13 2007-06-27 Fondazione Salvatore Maugeri - Clinica del Lavoro e della Riabilitazione Use of clarithromycin compositions in the manufacture of a medicament for the treatment of arthritis deformans
WO2005009368A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2005009365A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
CA2533358C (en) 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
EP1653925A1 (en) 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Robust pellet
AU2004264356B2 (en) 2003-08-12 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1658034A4 (en) * 2003-08-29 2011-06-22 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
CA2538064C (en) 2003-09-15 2013-12-17 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2005061524A2 (en) * 2003-12-22 2005-07-07 Ranbaxy Laboratories Limited Process for the preparation of form ii clarithromycin
US20050142187A1 (en) * 2003-12-24 2005-06-30 Treacy Donald J.Jr. Enhanced absorption of modified release dosage forms
AU2005209318B2 (en) * 2004-01-28 2010-02-11 Cytimmune Sciences, Inc. Functionalized colloidal metal compositions and methods
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
CA2572292A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
JP2009500356A (ja) * 2005-07-07 2009-01-08 エラン ファーマ インターナショナル リミテッド ナノ粒子クラリスロマイシン製剤
US20070122483A1 (en) * 2005-11-29 2007-05-31 Sharon Myers Fluocinolone acetonide drug substance polymorphic interconversion
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2011026234A1 (en) * 2009-09-02 2011-03-10 Bernard Charles Sherman Clarithromycin extended-release tablet
AU2014348523B2 (en) 2013-11-15 2019-01-03 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4331803A (en) 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS60214796A (ja) 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS61103890A (ja) 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
US4670549A (en) 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
US4640910A (en) 1985-11-12 1987-02-03 Abbott Laboratories Erythromycin A silylated compounds and method of use
US4672056A (en) 1985-11-12 1987-06-09 Abbott Laboratories Erythromycin A derivatives and method of use
KR960000434B1 (ko) 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
GB8721165D0 (en) 1987-09-09 1987-10-14 Beecham Group Plc Chemical compounds
JP2751385B2 (ja) 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5440505A (en) * 1994-01-21 1995-08-08 Intel Corporation Method and circuitry for storing discrete amounts of charge in a single memory element
US5872229A (en) 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives
US5756473A (en) 1995-11-21 1998-05-26 Abbott Laboratories 6-O-methyl erythromycin D and process for making
US5837829A (en) 1996-04-02 1998-11-17 Abbott Laboratories 9-oximesilyl erythromycin a derivatives
US5719272A (en) 1996-04-02 1998-02-17 Abbott Laboratories 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
US5808017A (en) 1996-04-10 1998-09-15 Abbott Laboratories Process for preparing erythromycin A oxime
US5858986A (en) 1996-07-29 1999-01-12 Abbott Laboratories Crystal form I of clarithromycin
US5844105A (en) * 1996-07-29 1998-12-01 Abbott Laboratories Preparation of crystal form II of clarithromycin
AU733646B2 (en) 1996-07-29 2001-05-17 Bgp Products Operations Gmbh Preparation of crystal form II of clarithromycin
US5945405A (en) 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
US5864023A (en) 1997-02-13 1999-01-26 Abbott Laboratories 3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
US5852180A (en) 1997-11-17 1998-12-22 Abbott Laboratories Chemical synthesis of 6-O-alkyl erythromycin A
US5932710A (en) 1997-12-01 1999-08-03 Abbott Laboratories Process for preparing 6-O-alkyl-9-oxime erythromycin B
US5892008A (en) 1997-12-16 1999-04-06 Abbott Laboratories Process for the preparation of 6-O-methyl erythromycin a using 9-hydroxy erythromycin derivatives
KR100377159B1 (ko) 1998-09-09 2003-08-19 한미약품공업 주식회사 잔류 용매가 없는 클라리스로마이신의 결정형 2의 제조 방법
IL150227A0 (en) * 1999-12-16 2002-12-01 Teva Pharma Processes for preparing clarithromycin polymorphs and novel polymorph iv
ATE288758T1 (de) * 2000-01-11 2005-02-15 Teva Pharma Verfahren zur herstellung von polymorphen des clarithromycins
IL151496A0 (en) * 2000-02-29 2003-04-10 Teva Pharma Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same

Also Published As

Publication number Publication date
US6624292B2 (en) 2003-09-23
HUP0204252A2 (hu) 2003-03-28
CA2397092A1 (en) 2001-07-19
US20020028920A1 (en) 2002-03-07
IS6463A (is) 2002-07-09
DE60018119D1 (de) 2005-03-17
EP1280535A1 (en) 2003-02-05
SI1280535T1 (pt) 2005-08-31
DE60018119T2 (de) 2006-05-04
DK1280535T3 (da) 2005-04-04
AU2001222619B8 (en) 2005-07-14
RU2002118308A (ru) 2004-02-20
BR0016992A (pt) 2002-12-31
US20030216555A1 (en) 2003-11-20
CN1450903A (zh) 2003-10-22
ZA200205229B (en) 2003-06-30
HUP0204252A3 (en) 2003-04-28
PL356645A1 (en) 2004-06-28
PT1280535E (pt) 2005-04-29
EP1280535A4 (en) 2003-02-05
KR20020071012A (ko) 2002-09-11
WO2001051059A1 (en) 2001-07-19
US6987175B2 (en) 2006-01-17
EP1280535B1 (en) 2005-02-09
AU2001222619B2 (en) 2005-04-28
JP2003519661A (ja) 2003-06-24
AU2001222619C1 (en) 2006-01-12
ATE288758T1 (de) 2005-02-15
ES2236023T3 (es) 2005-07-16
AU2261901A (en) 2001-07-24
HRP20020572A2 (en) 2005-04-30

Similar Documents

Publication Publication Date Title
IL150698A0 (en) Processes for preparing clarithromycin polymorphs
HK1055955A1 (en) Methanesulphonamido-benzofuran, preparation methodand use thereof as synthesis intermediate.
ZA200206253B (en) Oxygenate conversion process.
MXPA03005028A (es) Derivados de cetolida de 6-0-carbamoilo de eritromicina, utiles como antibacterianos.
ZA200110179B (en) Process for the preparation of pure citalopram.
IL150227A0 (en) Processes for preparing clarithromycin polymorphs and novel polymorph iv
HUP0302364A3 (en) Novel cyclodextrin glucanotransferase, process for producing the same and process for producing cyclodextrin by using this enzyme
MXPA03001590A (es) Anticuerpos para la il-1beta humana.
MXPA03000913A (es) Metodo para preparacion de citalopram.
AU2001222619A1 (en) Processes for preparing clarithromycin polymorphs
ZA200102070B (en) Process for preparing resorcinol derivatives.
ZA200108623B (en) Process for preparing imidachloprid.
HK1040984A1 (zh) 製備d，l-薄荷醇的方法
MXPA03002926A (es) Proceso para la sintesis de 2,2,6,6,-tetrametil-4--oxipiperidina.
YU53302A (sh) Postupci za pripremanje polimorfa klaritromicina
MXPA01012693A (es) Produccion mejorada de tequila.
ES2197790A1 (es) Compuesto intermedio de utilidad en la sintesis de macrolidos.
HK1057047A1 (en) Processes for preparing erythromycin derivatives and intermediates thereof.
IL152295A0 (en) Method for producing 2-alkyl-3-chlorophenols
TWI265166B (en) Process for preparing benzofuranone oximes
IL137364A (en) Process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
MXPA03002694A (es) Compuestos de 5-fenilbencilamina, procedimiento para su produccion e intermediarios para su sintesis.
HUP0302821A2 (hu) Eljárás szubsztituált 5-amino-N-fenil-1,2,4-triazol-3-szulfonamid-származékok előállítására
HK1060732A1 (en) Process for preparing distamycin derivatives.
GB0012129D0 (en) Solar steam production system